Weevaluated the influence of the levels of glycosylated hemoglobin (HbAlc) and fasting plasma glucose on the variation in low density lipoprotein (LDL) peak particle size in 210 subjects who were undergoing an annual check-up. Univariate analysis showed that LDLparticle size was significantly and positively correlated with high density lipoprotein (HDL) cholesterol levels, and was inversely correlated with the levels of total plasma cholesterol, triglycerides, fasting glucose, fasting insulin, HbAlc, and body mass index (BMI). Stepwise regression analysis selected four independent contributing variables that could affect LDLparticle size; triglyceride levels, HDL cholesterol levels, LDLcholesterol levels, and HbA1Clevels. Similar regression analysis performed for menand for normotensive subjects showedthat HbAlclevels also independently influenced LDLparticle size. The results indicate that HbAlc levels have a significant effect on LDLparticle size. This suggests that small LDLparticles would be present in subjects with non-insulindependent diabetes mellitus regardless of plasma lipid concentrations.
Introduction
Plasma concentrations of lipoprotein fraction are strongly associated with arteriosclerosis, and coronary artery disease in particular (1, 2) . An increased plasma concentration of low density lipoprotein (LDL) cholesterol is widely recognized as a risk factor for coronary artery disease (3) . The LDLparticles are the major carriers of plasmacholesterol. Suchparticles showa considerable variation in their size, density, and chemical composition (4, 5) . By the use of nondenaturing polyacrylamide gradient gel electrophoresis, Krauss and Burke identified and characterized multiple distinct subclasses of plasma LDLthat may possess differing metabolic and pathologic properties (6) .
People with a predominance of small LDLparticles appear to be at increased risk for coronary artery disease, independent of the presence of other risk factors (7, 8) . LDLsubclasses are divided into two LDLphenotypes according to size and are genetically influenced (9-1 1) . However, changes in LDLpartide size are inversely associated with changes in plasma triglyceride concentrations (12) . Size of the LDLparticle is influenced variously by hormones (13, 14) , the presence of diabetes mellitus (14-16), insulin resistance (17, 18) , and hypertension ( 19).
LDL particle size has been shown to depend on the dyslipidemia of diabetes, even though the diabetes itself was significantly associated with a smaller LDL particle (15). To further investigate the relationship between LDLparticle size and impaired glucose homeostasis, we evaluated glycosylated hemoglobin (HbAl c), fasting glucose, and fasting insulin levels in 210 subjects.
enrolled in the study. They were not taking hormones or receiving treatment for diabetes mellitus, hypertension, or hyperlipidemia. None were diagnosed with insulin-dependent diabetes mellitus.
Blood samples Samples of venous blood were collected from the antecubital vein between 09:30 and 10:30 after an overnight fast (restriction of drinking and eating after 20:00 on the preceding day). Sodium azide (0.0 1 %), merthiolate (0.005%), and disodium ethylenediaminetetraacetic acid (EDTA) (2.5 mmol//) were added to the blood specimen. Plasma was isolated by centrifugation at l,000g for 15 minutes at 4°C.
Determination of LDLparticle size
The diameter for the major peak in gel electrophoresis is called the peak size of the LDL particle. The LDL peak size was determined in fresh plasma samples according to the method of Krauss and Burke (6, 20) , with some modifications. There was no significant difference between the peak size of the LDL particle in the whole plasma and that of LDL(d=1.019-1,063 g/ml) isolated by ultracentrifugation (data not shown) as previously described (21). Nondenaturing 2%to 16% polyacrylamide gradient gels were purchased from Pharmacia Biotech (Uppsala, Sweden).
Plasma was mixed (4:1 by volume) with a solution that consisted of 40%sucrose and 0.05% bromophenol blue. Electrophoresis was carried out in TBEbuffer (pH 8.3) A quadratic equation using the relative migration distance of each sample was fitted to the logarithms of the diameters of the standards using the above computer program, and the peak particle diameter was calculated for each sample lane. Since more than one LDLpeak was often observed, and the highest peak rarely differed between the protein and lipid staining, the peak particle size was determined by lipid staining.
Baseline data collection Morning blood pressure was measured by using an automatic cuff with the subject seated. Body mass index (BMI) was calculated as weight (kg) divided by height (m2). Plasma levels of total cholesterol and of triglycerides were measured by enzymatic methods. The plasma level of high-density lipoprotein (HDL) cholesterol was determined with enzymatic reagents after precipitating the apolipoprotein B-containing lipoproteins by heparin, Ca2+, and Ni2+. The concentration of LDLcholesterol was calculated with the formula described by Friedewald et al (22) . Plasma glucose levels were measured by the glucose oxidase method and insulin levels by radioimmunoassay. HbAlc levels in whole blood were determined by high-performance liquid chromatography. The normal levels of HbAlc ranged from 4.0 to 6.0%.
Statistical analysis Data are given as mean± SD. Data were collected and stored in an Apple computer (Apple Japan, Inc., Tokyo) using the Statview 4. 1 1 software (Abacus Concepts, Inc., Berkeley, CA).
Unpaired Mests were used to comparethe meandifferences between two groups. Pearson product-moment correlation coefficients (r) were computedto identify the parameters that were significantly associated with variations in LDLpeak particle size. Forward stepwise multiple regression analysis was performed to examine significant contributions of these parameters to the prediction of the LDLsize variation. A level of p<0.05 was accepted as statistically significant.
Results
Baseline physical and metabolic characteristics of the 210 subjects are summarizedin Table 1 . There was no significant differences between menand womenas to age, total cholesterol levels, or LDLcholesterol levels. The men showed significantly higher levels of plasma triglycerides, fasting glucose, HbAlc, BMI, plasma insulin, and blood pressure, and lower levels of LDLparticle size and HDLcholesterol. Nineteen of the forty-seven womenwere postmenopausal. Interestingly, menopausal status was significantly associated with a smaller LDL particle size (260.73 ± 9.57 vs 268.31 ± 6.08 A, p=0.002) despite the lack of a significant difference in LDLcholesterol levels (3.61 ± 0.78 vs 3.22 ± 0.78 mmol/Z, p=0.10). Table 2 shows the Pearson correlation coefficients that relate LDLparticle size to each measured variable for menand women.In women,age was significantly and negatively correlated with LDL particle size (r=-0.290, p=0.048) probably due to a difference in menopausal status. Overall, there was a slight, but statistically significant, negative correlation between LDL size and age. Plasma concentrations oftriglycerides showedthe strongest negative correlation with LDLparticle size among the parameters measured (r=-0. 396, p<0.000 1 ). When triglyceride concentrations were transformed logarithmically to reduce the skewnessof the data, the magnitudeof this correlation coefficient increased to -0.439 (p<0.000 1). Overall, the LDL particle size was negatively correlated with the total plasma level of cholesterol but not with levels of LDLcholesterol, despite a significant correlation between these parameters in women. LDLparticle size was positively correlated with HDLcholesterol levels, whereas all other parameters exhibited negative correlations with LDLparticle size. HbAlc, fasting glucose, and fasting insulin levels, which are all associated with glucose homeostasis, were significantly and negatively correlated with LDLparticle size in men and womentogether (Table 2 and Fig.   1 ).
The subjects were then divided into normotensive and hypertensive subgroups. Hypertension was defined as a systolic blood pressure of 140 mmHgor greater, or a diastolic blood pressure of 90 mmHgor greater. The average size of the LDL particles in the hypertensive group (n=41) was 260.73 ± 9.65 A, which is not significant (p=0.056) when compared to normotensive subjects (263.37 ± 7.41 A) as shown in Table 3 .
With the subjects divided into subgroups according to BMI (>25 kg/m2 and <25 kg/m2), there was no longer a significant difference in LDLparticle size between these two groups (Table 3) although there was a significantly negative correlation between LDL particle size and the BMI (r=-0.236, p=0.0005) ( Table 2 ).
Wedivided the 210 subjects into two subgroups according to the levels offasting glucose and HbAlc. Those with a fasting glucose level of 6.7 mmol// or greater, or an HbAlc level of 6.5% or greater were considered to have impaired glucose metabolism. Fifteen of the 20 subjects in this group (n=24) had plasma glucose levels which were greater than 7.8 mmol// 2 hours after 75-g glucose load. A smaller LDLparticle was observed significantly more frequently in the subjects with higher levels of glucose and HbAlc (p<0.0039) ( Table 3 and Data are expressed as mean + SD. n: the number of subjects, NS: not significant. *Impaired glucose metabolism is defined as a fasting glucose level of 6.7 mmol// or greater, or an HbAlc level of 6.5% or greater.
ent factors capable of influencing LDLparticle size; plasma triglycerides, LDL cholesterol, HDLcholesterol, and HbAlc. This indicated that these four variances accounted for a 22.7% variance in the LDLparticle size. Whentriglyceride concentrations were transformed logarithmically, forward stepwise regression analysis selected three parameters as independent factors; plasma triglycerides, HDLcholesterol, and HbAlc. This gave an R2 of0.220, accounting for 22.0% of the variation in the LDLparticle size. Logarithmic transformation of triglyceride concentrations wasthe single most powerful predictor of LDL particle size (R2 = 0. 193). After adjusting for variations in triglycerides, LDL cholesterol, and HDLcholesterol, HbAlc levels were significantly related and increased R2 by 0.018 in the regression model (Table 4) .
A possibility for differences in LDL particle size may also exist between the normotensive and the hypertensive subjects. Astepwise regression analysis ofnormotensive subjects (n= 1 69) revealed that HbAlc levels were a significant predictor of LDL size independent of plasma lipids. Since LDLsize was significantly and inversely correlated with age in women, we also used a stepwise regression analysis to evaluate men(n=163). Again, HbAlc and fasting glucose levels were significant predictors of LDLparticle size independent of plasma lipid levels ( LDL particle size (A) Figure 2 . Histograms for the LDLparticle size distribution in nondiabetic subjects (A, n=186) and in subjects with impaired glucose metabolism (B, n=24). Impaired glucose metabolism is defined as a fasting glucose level of 6.7 mmol// or greater, or an HbAlc level of 6.5% or greater.
Discussion
A smaller LDL particle is associated with reduced plasma levels of HDLcholesterol and increased levels of plasma triglycerides (10, ll, 23) . The present study showed that the elevations in HbAlc and fasting glucose levels, both of which are strongly associated with the prevalence of diabetes, contributed to the LDLpeak particle sizes independent of lipoprotein and lipid concentrations. The measurement ofHbAlc is recommendedby the American Diabetes Association for the monitoring of long-term blood glucose levels and as a marker of glycemic control in diabetic patients (24). HbAlc measurements have gained increased attention as a stable biochemical measure relative to labile fasting glucose levels (25). Previous studies have shownthat LDLsize is significantly lower in diabetic than in nondiabetic subjects. However, since diabetic dyslipidemia greatly influences the LDL size distribution, the effects of diabetes on LDLsize are no longer significant after adjustment for diabetic dyslipidemia (14, 15). Previous studies included diabetic subj ects treated with oral antidiabetic agents and insulin injections, with patients being divided into indicates an independent factor (F value >4.0) after adjusting for variations in plasma lipid levels, n indicates the number of subjects. Impaired glucose metabolism is defined as a fasting glucose level of 6.7 mmol// or greater, or an HbAlc level of6.5% or greater. Ln: natural logarithm, r: partial correlation coefficient, F: F ratio, R2: square of the multiple correlation coefficient.
only two groups, diabetic and nondiabetic. In the present study, HbAlcand fasting glucose levels were used to ascertain the degree of impaired glucose homeostasis in our untreated subjects attending a routine check-up. Whenthese subjects were then divided into two groups according to their HbAlc and fasting glucose levels, the variation in LDLsize was significantly different between the two subgroups. However, after adjustment for variations in plasma lipid levels, there was no longer a significant effect by the group with higher levels of HbAlc or fasting glucose (Table 4) . On the other hand, HbAlc and fasting glucose levels were still correlated with the variation in LDLparticle size although the subjects with very high levels of HbAlc or fasting glucose contributed greatly to the correlation as shown in Fig. 1 . The precise mechanism is unknown. Glycation and oxidation of amines in LDL may be associated with the alteration of LDLparticle size (26). The measurement of dynamic parameters such as HbAlc and fasting glucose levels as indicators of the degree of impaired glucose homeostasis lent itself to multiple regression analysis. Insulin resistance, which is characterized by an impaired tissue sensitivity to insulin, thereby causing hyperinsulinemia and dyslipidemic hypertension, is also associated with a small LDL particle (17, 18). However, Reaven et al indicated that the plasma triglyceride concentration was the only independent predictor for LDLparticle size in patients with insulin resistance, hyperinsulinemia, and diabetes ( 17). In the present study, the fasting insulin concentration was more closely correlated with the BMI (r=0.565, p<0.0001), triglyceride levels (for logarithmic transformation; r=0.301 , p<0.000 1) and HDLcholesterol levels (r=-0.379, p<0.0001) than with fasting glucose levels (r=0.232, p=0.0007) and HbAlc levels (r=0.207, p=0.0025), confirming that the fasting insulin concentration reflects insulin resistance rather than impaired glucose metabolism. Evidence that the fasting plasma insulin concentration is not an independent predictor of LDLsize because of its correlation with lipid metabolism is consistent with previous studies (17, 18) .
The size ofLDLparticles appears to be influenced by genetic factors (9-1 1) . With a reduction in body weight and fat content, however, there was a small but significant increase in LDL particle size amongthe menwith initially small LDLparticles. These increases wereaccompaniedby decreases in plasma levels of triglycerides and insulin (19). On the other hand, the decrease in plasma triglyceride levels after treatment with a fibrate lipid-lowering agent gemfibrozil did not increase LDL size (27), suggesting that gemfibrozil decreased mainly very low density lipoprotein (VLDL) consisting of triglyceride rich particles. In the present study, age was significantly associated with the LDLparticle size distribution in womenbut not in men, which suggests that menopausal status affects the LDLsize distribution. Several mechanisms, including genetic and environmental factors, may be involved in determining the predominant size of the LDLparticle in an individual. The small LDLparticle is a proposed marker for atherogenic lipoprotein and a high risk of coronary heart disease (1 1). The higher frequency of small LDLparticles observed in the postmenopausal womenin the present study coincides with the higher incidence of coronary heart disease reported after menopause. Although LDLparticle size contributed to the known heterogeneity ofLDL, a Pearson correlation coefficient derived from LDLsize and LDLcholesterol level was very poor and not significant. This finding is consistent with results of a previous study (28). The distribution of LDLparticle sizes was almost identical to that obtained by density gradient ultracentrifugation (29). The smaller dominant LDLparticle may be attributable to a direct remodeling of certain LDL sub fractions (9, 30) and the actions of lipid transfer proteins and lipases (31).
Therefore, the difference in LDLparticle size is more likely to be associated with lipid composition. Werecently showed that the triglyceride-to-protein ratio in LDLand the percentage of arachidonate in LDLtriglycerides were increased in rats with chronic hyperinsulinemia (32).
A possible explanation for the atherogenicity of LDLis that smaller, more dense LDLbinds to the arterial wall with a greater affinity than larger LDL (33). The dense LDLsub fraction is more susceptible to oxidative modification, which mayfurther enhance its atherogenicity (34-36). The lipid composition and the peak particle size of LDLin pathophysiological conditions requires further study to clearly define the physical contribution of LDLto atherogenesis.
